Neurocrine Biosciences Inc Financial Flexibility Index
Neurocrine Biosciences Inc financial flexibility index. Neurocrine Biosciences Inc (NBIX) has a Financial Flexibility Index of 0.28x as of December 2025. Free cash flow of $390.80 Million (operating CF $388.40 Million minus capex $2.40 Million) represents 0% of total liabilities ($1.38 Billion). Explore Neurocrine Biosciences Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Neurocrine Biosciences Inc (1996–2025)
Financial flexibility index of Neurocrine Biosciences Inc from 1996 to 2025. Historical Financial Flexibility Index trend for Neurocrine Biosciences Inc across 30 annual periods. Check cash flow reinvestment rate of Neurocrine Biosciences Inc to assess the company's total reinvestment commitment from operating cash flow.
Neurocrine Biosciences Inc Financial Flexibility Index by Year (1996–2025)
Neurocrine Biosciences Inc financial flexibility index by year from 1996 to 2025. Year-by-year free cash flow to debt coverage for Neurocrine Biosciences Inc. For the full cash flow conversion analysis, see Neurocrine Biosciences Inc cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | $816.70 Million | $782.70 Million | $1.38 Billion | ▲ +5.6% |
| 2024 | 0.56x | $633.60 Million | $595.40 Million | $1.13 Billion | ▲ +36.8% |
| 2023 | 0.41x | $418.20 Million | $389.90 Million | $1.02 Billion | ▼ -23.8% |
| 2022 | 0.54x | $355.90 Million | $339.40 Million | $660.90 Million | ▲ +34.4% |
| 2021 | 0.40x | $279.90 Million | $256.50 Million | $698.50 Million | ▲ +1.9% |
| 2020 | 0.39x | $239.40 Million | $228.50 Million | $608.50 Million | ▲ +62.8% |
| 2019 | 0.24x | $161.70 Million | $147.00 Million | $669.10 Million | ▼ -1.9% |
| 2018 | 0.25x | $126.20 Million | $101.40 Million | $512.39 Million | ▲ +225.5% |
| 2017 | -0.20x | $-87.39 Million | $-94.33 Million | $445.45 Million | ▲ +90.3% |
| 2016 | -2.03x | $-102.07 Million | $-106.18 Million | $50.21 Million | ▼ -183.7% |
| 2015 | -0.72x | $-36.06 Million | $-38.00 Million | $50.33 Million | ▲ +46.0% |
| 2014 | -1.33x | $-45.53 Million | $-47.14 Million | $34.33 Million | ▼ -56.3% |
| 2013 | -0.85x | $-29.06 Million | $-29.61 Million | $34.27 Million | ▼ -2.8% |
| 2012 | -0.82x | $-34.32 Million | $-35.29 Million | $41.61 Million | ▼ -124295.3% |
| 2011 | 0.00x | $52.00K | $-698.00K | $78.29 Million | ▼ -99.8% |
| 2010 | 0.40x | $50.26 Million | $49.94 Million | $125.08 Million | ▲ +150.6% |
| 2009 | -0.79x | $-53.06 Million | $-53.09 Million | $66.86 Million | ▲ +11.3% |
| 2008 | -0.89x | $-72.84 Million | $-74.17 Million | $81.41 Million | ▼ -140.7% |
| 2007 | -0.37x | $-58.71 Million | $-59.33 Million | $157.96 Million | ▲ +71.0% |
| 2006 | -1.28x | $-96.22 Million | $-99.33 Million | $74.96 Million | ▼ -406.8% |
| 2005 | -0.25x | $-23.56 Million | $-30.79 Million | $93.02 Million | ▲ +32.2% |
| 2004 | -0.37x | $-46.84 Million | $-99.99 Million | $125.39 Million | ▼ -169.9% |
| 2003 | 0.53x | $87.57 Million | $37.13 Million | $163.84 Million | ▲ +130.5% |
| 2002 | -1.75x | $-74.06 Million | $-79.36 Million | $42.28 Million | ▼ -248.9% |
| 2001 | -0.50x | $-18.05 Million | $-21.86 Million | $35.96 Million | ▲ +29.5% |
| 2000 | -0.71x | $-16.20 Million | $-18.64 Million | $22.75 Million | ▼ -11.2% |
| 1999 | -0.64x | $-8.20 Million | $-10.30 Million | $12.80 Million | ▲ +22.2% |
| 1998 | -0.82x | $-7.00 Million | $-10.70 Million | $8.50 Million | ▼ -141.2% |
| 1997 | 2.00x | $17.40 Million | $11.00 Million | $8.70 Million | ▲ +25.3% |
| 1996 | 1.60x | $8.30 Million | $6.70 Million | $5.20 Million | — |